An Observational Study on Sarilumab-exposed Pregnancies

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Primary Objective: To evaluate the relative risk of major structural birth defects, specifically a pattern of anomalies, in sarilumab-exposed pregnancies compared to disease-matched unexposed pregnancies. Secondary Objective: To evaluate the risk for sarilumab-exposure relative to the group of healthy pregnant women, and the effect of exposure on other adverse pregnancy and infants outcomes.
Epistemonikos ID: 9de598c662bd4ea97666ee16990d80a39b8ae55e
First added on: May 21, 2024